CN Stock MarketDetailed Quotes

300937 Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical

Watchlist
  • 31.63
  • +0.13+0.41%
Market Closed Dec 13 15:00 CST
3.03BMarket Cap129.63P/E (TTM)

Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash
-21.76%2.43B
-17.15%1.7B
26.25%977.65M
10.11%4.2B
43.98%3.11B
47.67%2.05B
23.22%774.39M
-0.92%3.82B
8.56%2.16B
11.15%1.39B
Refunds of taxes and levies
220.65%310.92K
416.57%287.52K
1,149.23%504.86K
--88.77K
-91.75%96.96K
-94.64%55.66K
-56.48%40.41K
--0
-1.39%1.17M
78.77%1.04M
Cash received relating to other operating activities
-72.37%42.78M
6.45%17.5M
46.07%5.61M
-63.21%8.31M
391.47%154.86M
0.89%16.44M
-74.65%3.84M
103.21%22.6M
125.73%31.51M
66.33%16.3M
Cash inflows from operating activities
-24.15%2.47B
-16.95%1.71B
26.40%983.77M
9.68%4.21B
48.90%3.26B
47.02%2.06B
20.90%778.27M
-0.62%3.84B
9.37%2.19B
11.61%1.4B
Goods services cash paid
-29.81%2.1B
-23.89%1.5B
20.32%952.53M
16.57%3.99B
51.43%2.99B
54.78%1.97B
25.63%791.69M
-10.53%3.42B
-2.22%1.97B
-3.17%1.27B
Staff behalf paid
5.97%119.74M
5.11%83.01M
2.06%45.59M
15.02%151.13M
18.32%112.99M
22.70%78.97M
30.12%44.67M
30.22%131.39M
29.41%95.5M
27.48%64.36M
All taxes paid
-18.06%41.11M
-24.62%29.78M
-42.45%13.22M
47.47%65.44M
59.38%50.17M
95.78%39.51M
134.08%22.97M
44.16%44.38M
17.56%31.48M
-7.55%20.18M
Cash paid relating to other operating activities
-25.94%177.99M
50.11%102.37M
23.23%44.47M
36.59%118.89M
288.06%240.34M
103.76%68.19M
34.42%36.09M
47.46%87.04M
6.59%61.93M
58.33%33.47M
Cash outflows from operating activities
-28.17%2.44B
-20.50%1.71B
17.91%1.06B
17.36%4.33B
56.86%3.39B
55.07%2.15B
27.70%895.41M
-8.24%3.69B
-0.66%2.16B
-1.21%1.39B
Net cash flows from operating activities
129.74%38.32M
103.84%3.38M
38.50%-72.04M
-175.64%-115.47M
-544.65%-128.85M
-641.72%-87.88M
-103.94%-117.14M
198.89%152.67M
116.73%28.98M
111.04%16.22M
Investing cash flow
Cash received from disposal of investments
-29.64%9.03M
-66.69%3M
-16.67%2M
794.90%10.94M
--12.84M
--9.01M
--2.4M
-50.11%1.22M
----
----
Cash received from returns on investments
-36.53%77.38K
-3.96%76.64K
26.47%39.97K
1,048.95%3.66M
-16.23%121.91K
17.22%79.8K
-53.58%31.6K
64.71%318.46K
--145.53K
--68.08K
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset
7,616.10%2.9M
2,581.37%335.79K
--20.53K
589.51%536.97K
46.57%37.52K
-57.48%12.52K
----
1,177.19%77.88K
-61.48%25.6K
-58.65%29.45K
Net cash received from disposal of subsidiaries and other business units
--1.1M
--1.1M
----
821.36%3.03M
----
----
----
478.95%329.32K
----
----
Cash received relating to other investing activities
-99.98%728.58
----
----
-99.65%73K
-87.24%3.22M
-85.09%3.15M
----
--20.89M
29,169.88%25.26M
--21.13M
Cash inflows from investing activities
-19.20%13.11M
-63.16%4.51M
-15.26%2.06M
-20.12%18.24M
-36.23%16.22M
-42.29%12.25M
2,495.63%2.43M
791.14%22.84M
867.23%25.43M
771.93%21.23M
Cash paid to acquire fixed assets intangible assets and other long-term assets
1.46%18.13M
20.65%15.05M
-24.85%5.37M
92.81%35.33M
-10.44%17.87M
-31.45%12.48M
-44.15%7.15M
-41.70%18.32M
-21.83%19.96M
-9.02%18.2M
Cash paid to acquire investments
83.02%19.82M
-26.84%7.57M
122.58%5.97M
25.25%18.66M
-55.37%10.83M
44.87%10.35M
-44.13%2.68M
-85.54%14.9M
116.69%24.27M
42.90%7.14M
 Net cash paid to acquire subsidiaries and other business units
--0
----
----
--0
----
----
----
--0
----
----
Impawned loan net increase
--0
----
----
--0
----
----
----
--0
----
----
Cash paid relating to other investing activities
--88.81K
--59.83K
--59.83K
--99.29M
----
----
----
--0
----
----
Cash outflows from investing activities
32.55%38.05M
-0.62%22.69M
15.99%11.41M
361.39%153.28M
-35.10%28.7M
-9.93%22.83M
255.50%9.83M
-75.30%33.22M
20.41%44.23M
1.36%25.35M
Net cash flows from investing activities
-99.79%-24.94M
-71.80%-18.17M
-26.25%-9.34M
-1,200.19%-135.04M
33.57%-12.48M
-156.70%-10.58M
-215.34%-7.4M
92.13%-10.39M
44.89%-18.79M
81.74%-4.12M
Financing cash flow
Cash received from capital contributions
-92.55%298K
-90.07%298K
--0
85.61%4M
85.61%4M
96.72%3M
96.72%3M
-99.25%2.16M
-99.24%2.16M
-99.46%1.53M
-Including: Cash received from capital contributions by minority shareholders of subsidiaries
-92.55%298K
-90.07%298K
----
44.67%4M
--4M
--3M
96.72%3M
-99.04%2.77M
----
----
Cash from borrowing
183.33%263.5M
240.00%85M
--176M
78.25%330.5M
9.70%93M
-4.21%25M
----
42.41%185.42M
323.90%84.78M
30.50%26.1M
Cash received relating to other financing activities
----
----
--0
--0
----
----
----
--0
----
----
Cash inflows from financing activities
171.96%263.8M
204.64%85.3M
5,766.67%176M
78.33%334.5M
11.58%97M
1.36%28M
-88.69%3M
-55.22%187.57M
-71.35%86.93M
-90.89%27.63M
Borrowing repayment
117.84%295M
-10.09%94.5M
-16.52%88M
63.94%195.42M
170.84%135.42M
425.51%105.1M
427.09%105.42M
133.73%119.2M
25.00%50M
-50.00%20M
Dividend interest payment
18.63%27.91M
13.01%25.77M
6.94%2.29M
369.95%24.93M
505.95%23.52M
740.19%22.8M
60.11%2.14M
-74.33%5.31M
-80.43%3.88M
-86.17%2.71M
-Including:Cash payments for dividends or profit to minority shareholders
--0
--0
----
--814.4K
--814.4K
--814.4K
--549.22K
--0
----
----
Cash payments relating to other financing activities
52.59%14.71M
55.69%5.97M
58.30%2.96M
14.41%6.73M
--9.64M
321.39%3.83M
--1.87M
-71.19%5.88M
----
-94.91%909.73K
Cash outflows from financing activities
100.27%337.62M
-4.17%126.24M
-14.79%93.25M
74.16%227.08M
212.88%168.59M
457.65%131.73M
412.91%109.43M
41.59%130.39M
-32.14%53.88M
-69.51%23.62M
Net cash flows from financing activities
-3.13%-73.82M
60.54%-40.94M
177.75%82.75M
87.84%107.42M
-316.58%-71.59M
-2,692.30%-103.73M
-2,150.58%-106.43M
-82.50%57.18M
-85.24%33.05M
-98.23%4M
Net cash flow
Exchange rate change effecting cash and cash equivalents
83.95%-154.79
-65.87%832.38
109.27%199.74
-5,446.39%-2.82K
---964.5
--2.44K
---2.15K
---50.92
----
----
Net increase in cash and cash equivalents
71.61%-60.45M
72.43%-55.73M
100.59%1.37M
-171.74%-143.1M
-592.43%-212.92M
-1,355.62%-202.19M
-403.95%-230.98M
392.60%199.47M
159.40%43.24M
-71.32%16.1M
Add:Begin period cash and cash equivalents
-42.77%191.49M
-42.77%191.49M
-42.77%191.49M
147.62%334.59M
147.62%334.59M
147.62%334.59M
147.62%334.59M
42.79%135.13M
44.27%135.13M
44.23%135.13M
End period cash equivalent
7.71%131.05M
2.54%135.76M
86.13%192.86M
-42.77%191.49M
-31.79%121.67M
-12.45%132.4M
16.04%103.62M
147.62%334.59M
61.67%178.36M
0.93%151.23M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Operating Cash Flow
Goods sale service render cash -21.76%2.43B-17.15%1.7B26.25%977.65M10.11%4.2B43.98%3.11B47.67%2.05B23.22%774.39M-0.92%3.82B8.56%2.16B11.15%1.39B
Refunds of taxes and levies 220.65%310.92K416.57%287.52K1,149.23%504.86K--88.77K-91.75%96.96K-94.64%55.66K-56.48%40.41K--0-1.39%1.17M78.77%1.04M
Cash received relating to other operating activities -72.37%42.78M6.45%17.5M46.07%5.61M-63.21%8.31M391.47%154.86M0.89%16.44M-74.65%3.84M103.21%22.6M125.73%31.51M66.33%16.3M
Cash inflows from operating activities -24.15%2.47B-16.95%1.71B26.40%983.77M9.68%4.21B48.90%3.26B47.02%2.06B20.90%778.27M-0.62%3.84B9.37%2.19B11.61%1.4B
Goods services cash paid -29.81%2.1B-23.89%1.5B20.32%952.53M16.57%3.99B51.43%2.99B54.78%1.97B25.63%791.69M-10.53%3.42B-2.22%1.97B-3.17%1.27B
Staff behalf paid 5.97%119.74M5.11%83.01M2.06%45.59M15.02%151.13M18.32%112.99M22.70%78.97M30.12%44.67M30.22%131.39M29.41%95.5M27.48%64.36M
All taxes paid -18.06%41.11M-24.62%29.78M-42.45%13.22M47.47%65.44M59.38%50.17M95.78%39.51M134.08%22.97M44.16%44.38M17.56%31.48M-7.55%20.18M
Cash paid relating to other operating activities -25.94%177.99M50.11%102.37M23.23%44.47M36.59%118.89M288.06%240.34M103.76%68.19M34.42%36.09M47.46%87.04M6.59%61.93M58.33%33.47M
Cash outflows from operating activities -28.17%2.44B-20.50%1.71B17.91%1.06B17.36%4.33B56.86%3.39B55.07%2.15B27.70%895.41M-8.24%3.69B-0.66%2.16B-1.21%1.39B
Net cash flows from operating activities 129.74%38.32M103.84%3.38M38.50%-72.04M-175.64%-115.47M-544.65%-128.85M-641.72%-87.88M-103.94%-117.14M198.89%152.67M116.73%28.98M111.04%16.22M
Investing cash flow
Cash received from disposal of investments -29.64%9.03M-66.69%3M-16.67%2M794.90%10.94M--12.84M--9.01M--2.4M-50.11%1.22M--------
Cash received from returns on investments -36.53%77.38K-3.96%76.64K26.47%39.97K1,048.95%3.66M-16.23%121.91K17.22%79.8K-53.58%31.6K64.71%318.46K--145.53K--68.08K
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset 7,616.10%2.9M2,581.37%335.79K--20.53K589.51%536.97K46.57%37.52K-57.48%12.52K----1,177.19%77.88K-61.48%25.6K-58.65%29.45K
Net cash received from disposal of subsidiaries and other business units --1.1M--1.1M----821.36%3.03M------------478.95%329.32K--------
Cash received relating to other investing activities -99.98%728.58---------99.65%73K-87.24%3.22M-85.09%3.15M------20.89M29,169.88%25.26M--21.13M
Cash inflows from investing activities -19.20%13.11M-63.16%4.51M-15.26%2.06M-20.12%18.24M-36.23%16.22M-42.29%12.25M2,495.63%2.43M791.14%22.84M867.23%25.43M771.93%21.23M
Cash paid to acquire fixed assets intangible assets and other long-term assets 1.46%18.13M20.65%15.05M-24.85%5.37M92.81%35.33M-10.44%17.87M-31.45%12.48M-44.15%7.15M-41.70%18.32M-21.83%19.96M-9.02%18.2M
Cash paid to acquire investments 83.02%19.82M-26.84%7.57M122.58%5.97M25.25%18.66M-55.37%10.83M44.87%10.35M-44.13%2.68M-85.54%14.9M116.69%24.27M42.90%7.14M
 Net cash paid to acquire subsidiaries and other business units --0----------0--------------0--------
Impawned loan net increase --0----------0--------------0--------
Cash paid relating to other investing activities --88.81K--59.83K--59.83K--99.29M--------------0--------
Cash outflows from investing activities 32.55%38.05M-0.62%22.69M15.99%11.41M361.39%153.28M-35.10%28.7M-9.93%22.83M255.50%9.83M-75.30%33.22M20.41%44.23M1.36%25.35M
Net cash flows from investing activities -99.79%-24.94M-71.80%-18.17M-26.25%-9.34M-1,200.19%-135.04M33.57%-12.48M-156.70%-10.58M-215.34%-7.4M92.13%-10.39M44.89%-18.79M81.74%-4.12M
Financing cash flow
Cash received from capital contributions -92.55%298K-90.07%298K--085.61%4M85.61%4M96.72%3M96.72%3M-99.25%2.16M-99.24%2.16M-99.46%1.53M
-Including: Cash received from capital contributions by minority shareholders of subsidiaries -92.55%298K-90.07%298K----44.67%4M--4M--3M96.72%3M-99.04%2.77M--------
Cash from borrowing 183.33%263.5M240.00%85M--176M78.25%330.5M9.70%93M-4.21%25M----42.41%185.42M323.90%84.78M30.50%26.1M
Cash received relating to other financing activities ----------0--0--------------0--------
Cash inflows from financing activities 171.96%263.8M204.64%85.3M5,766.67%176M78.33%334.5M11.58%97M1.36%28M-88.69%3M-55.22%187.57M-71.35%86.93M-90.89%27.63M
Borrowing repayment 117.84%295M-10.09%94.5M-16.52%88M63.94%195.42M170.84%135.42M425.51%105.1M427.09%105.42M133.73%119.2M25.00%50M-50.00%20M
Dividend interest payment 18.63%27.91M13.01%25.77M6.94%2.29M369.95%24.93M505.95%23.52M740.19%22.8M60.11%2.14M-74.33%5.31M-80.43%3.88M-86.17%2.71M
-Including:Cash payments for dividends or profit to minority shareholders --0--0------814.4K--814.4K--814.4K--549.22K--0--------
Cash payments relating to other financing activities 52.59%14.71M55.69%5.97M58.30%2.96M14.41%6.73M--9.64M321.39%3.83M--1.87M-71.19%5.88M-----94.91%909.73K
Cash outflows from financing activities 100.27%337.62M-4.17%126.24M-14.79%93.25M74.16%227.08M212.88%168.59M457.65%131.73M412.91%109.43M41.59%130.39M-32.14%53.88M-69.51%23.62M
Net cash flows from financing activities -3.13%-73.82M60.54%-40.94M177.75%82.75M87.84%107.42M-316.58%-71.59M-2,692.30%-103.73M-2,150.58%-106.43M-82.50%57.18M-85.24%33.05M-98.23%4M
Net cash flow
Exchange rate change effecting cash and cash equivalents 83.95%-154.79-65.87%832.38109.27%199.74-5,446.39%-2.82K---964.5--2.44K---2.15K---50.92--------
Net increase in cash and cash equivalents 71.61%-60.45M72.43%-55.73M100.59%1.37M-171.74%-143.1M-592.43%-212.92M-1,355.62%-202.19M-403.95%-230.98M392.60%199.47M159.40%43.24M-71.32%16.1M
Add:Begin period cash and cash equivalents -42.77%191.49M-42.77%191.49M-42.77%191.49M147.62%334.59M147.62%334.59M147.62%334.59M147.62%334.59M42.79%135.13M44.27%135.13M44.23%135.13M
End period cash equivalent 7.71%131.05M2.54%135.76M86.13%192.86M-42.77%191.49M-31.79%121.67M-12.45%132.4M16.04%103.62M147.62%334.59M61.67%178.36M0.93%151.23M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%